MeVis Medical Solutions AG (FRA:M3V)

FRA:M3V Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	6.53	7.74	9.32	7.62	3.95
Cash & Short-Term Investments	6.53	7.74	9.32	7.62	3.95
Cash Growth	-15.70%	-16.91%	22.30%	92.76%	52.05%
Accounts Receivable	2.24	2.65	4.01	2.27	2.75
Other Receivables	0.77	0.62	0.73	0.53	3.9
Receivables	3.02	3.27	4.74	2.8	6.65
Other Current Assets	0	0.31	0.31	0.35	0.41
Total Current Assets	9.55	11.33	14.37	10.77	11.01
Property, Plant & Equipment	0.32	0.15	0.16	0.12	0.19
Long-Term Investments	0.3	0.31	0.31	0.31	0.31
Other Intangible Assets	-	-	0	0	0
Other Long-Term Assets	0.1	0.05	0.13	0.1	0.05
Total Assets	26.48	28.05	31.2	27.53	27.79
Accounts Payable	0.09	0.08	0.19	0.24	0.09
Accrued Expenses	1.3	1.48	1.81	1.36	0.14
Current Income Taxes Payable	-	0.17	0.17	0.25	0.17
Other Current Liabilities	0.93	1.04	0.84	0.51	-
Total Current Liabilities	2.31	2.76	3.01	2.36	0.4
Long-Term Unearned Revenue	1.53	1.54	1.52	1.76	1.57
Other Long-Term Liabilities	4.57	5.66	8.31	5.1	7.63
Total Liabilities	8.66	10.23	13.38	9.71	9.96
Common Stock	1.82	1.82	1.82	1.82	1.82
Additional Paid-In Capital	11.46	11.46	11.46	11.46	11.46
Retained Earnings	4.54	4.54	4.54	4.54	4.54
Shareholders' Equity	17.83	17.83	17.83	17.83	17.83
Total Liabilities & Equity	26.48	28.05	31.2	27.53	27.79
Net Cash (Debt)	6.53	7.74	9.32	7.62	3.95
Net Cash Growth	-15.70%	-16.91%	22.30%	92.76%	52.05%
Net Cash Per Share	3.59	4.25	5.12	4.19	2.17
Filing Date Shares Outstanding	1.82	1.82	1.82	1.82	1.82
Total Common Shares Outstanding	1.82	1.82	1.82	1.82	1.82
Working Capital	7.24	8.56	11.36	8.41	10.6
Book Value Per Share	9.79	9.79	9.79	9.79	9.79
Tangible Book Value	17.83	17.83	17.83	17.83	17.82
Tangible Book Value Per Share	9.79	9.79	9.79	9.79	9.79
Machinery	1.99	1.99	1.91	1.78	1.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.